Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chime Biologics is a leading international contract development and manufacturing organization (CDMO) focused on providing end-to-end biologics solutions. Headquartered in Wuhan, China, the company operates the world's first modular biologics manufacturing facility based on GE Healthcare's KUBio technology. Chime Biologics offers a comprehensive suite of services ranging from cell line development and process development to clinical and commercial-scale GMP manufacturing. The company was established following the restructuring of JHL Biotech's manufacturing assets and has since secured significant investment to expand its global capacity. It serves a diverse clientele of biotechnology and pharmaceutical companies, facilitating the rapid development and market entry of complex biologics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chime Supply.